Callan Family Office’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.87M Buy
76,134
+204
+0.3% +$13.4K 0.1% 205
2026
Q1
$5.4M Buy
75,930
+16,390
+28% +$1.29M 0.12% 179
2025
Q4
$4.88M Buy
59,540
+5,510
+10% +$429K 0.1% 191
2025
Q3
$4.06M Sell
54,030
-2,177
-4% -$162K 0.13% 169
2025
Q2
$4.16M Buy
56,207
+39,152
+230% +$2.73M 0.13% 173
2025
Q1
$1.38M Sell
17,055
-138
-0.8% -$11.9K 0.1% 169
2024
Q4
$1.34M Buy
+17,193
New +$1.46M 0.09% 197
2023
Q2
– Sell
-4,899
Closed -$402K – 130
2023
Q1
$402K Buy
+4,899
New +$350K 0.1% 108

Other funds holding GEHC

Callan Family Office's GEHC Position: Q2 2026 in Review

Callan Family Office increased its GE HealthCare (GEHC) stake by 0.27% in Q2 2026, buying an estimated $13.4K and bringing the position to 76,134 shares worth $4.87M. The position accounts for 0.1% of the portfolio, ranked #205.

Callan Family Office first reported a position in GEHC in Q1 2023 and has held it in 8 quarters since. The position peaked at $5.4M in Q1 2026. 1,233 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Callan Family Office held 76,134 shares of GE HealthCare worth $4.87M as of Q2 2026.
  • Callan Family Office bought 204 GE HealthCare shares in Q2 2026, an estimated $13.4K.
  • GE HealthCare made up 0.1% of Callan Family Office's portfolio in Q2 2026, its #205 holding.
  • Callan Family Office first reported a position in GE HealthCare in Q1 2023 and has held it in 8 quarters since.
  • Callan Family Office's GE HealthCare position peaked at $5.4M in Q1 2026.
  • 1,233 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.